1. Home
  2. CRIS
Logo Curis Inc.

CRIS

Curis Inc.

as 03-28-2025 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Founded: 2000 Country:
United States
United States
Employees: N/A City: LEXINGTON
Market Cap: 32.8M IPO Year: 2000
Target Price: $23.00 AVG Volume (30 days): 39.4K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -6.88 EPS Growth: N/A
52 Week Low/High: $2.30 - $17.49 Next Earning Date: 05-06-2025
Revenue: $10,908,000 Revenue Growth: 0.44%
Revenue Growth (this year): -1.84% Revenue Growth (next year): -16.04%

CRIS Daily Stock ML Predictions

Share on Social Networks: